APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cat Medicines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cat Medicines Market Outlook and Growth Opportunities 2026

29 December 2025205 pages

Choose your research edition.

Industry ResearchCat Medicines Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Cat Medicines Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Cat Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cat Medicines Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cat Medicines Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Cat Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cat Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cat Medicines market include Wuhan Chopperlvya Animal Health, Zoetis, Tianjin Ringpu Bio-technology, Nanjing Jindun Animal Pharmaceutical, Jining Wanhe Biotechnology (Belcol), Pfizer, Harbin Pharmaceutical Group, Taizhou Boleideli Biotechnology and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cat Medicines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cat Medicines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cat Medicines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cat Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.

Cat Medicines Segment by Company

Wuhan Chopperlvya Animal Health

Zoetis

Tianjin Ringpu Bio-technology

Nanjing Jindun Animal Pharmaceutical

Jining Wanhe Biotechnology (Belcol)

Pfizer

Harbin Pharmaceutical Group

Taizhou Boleideli Biotechnology

Virbac

Vetoquinol

Merck

IDEXX

Elanco

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Cat Medicines Segment by Type

Antiparasitic Drugs

Dermatological Drugs

Digestive System Drugs

Others

Cat Medicines Segment by Application

Online

Offline

Cat Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cat Medicines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cat Medicines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cat Medicines significant trends, drivers, influence factors in global and regions.

6. To analyze Cat Medicines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cat Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cat Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cat Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cat Medicines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cat Medicines industry.

Chapter 3: Detailed analysis of Cat Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cat Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cat Medicines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cat Medicines Industry Trends Table 2. Cat Medicines Industry Drivers Table 3. Cat Medicines Industry Opportunities and Challenges Table 4. Cat Medicines Industry Restraints Table 5. Global Cat Medicines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cat Medicines Revenue Share by Company (2021-2026) Table 7. Global Cat Medicines Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Cat Medicines Sales Volume Share by Company (2021-2026) Table 9. Global Cat Medicines Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Cat Medicines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cat Medicines Key Company Manufacturing Base & Headquarters Table 12. Global Cat Medicines Company, Product Type & Application Table 13. Global Cat Medicines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cat Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antiparasitic Drugs Table 18. Significant Companies of Dermatological Drugs Table 19. Significant Companies of Digestive System Drugs Table 20. Significant Companies of Others Table 21. Global Cat Medicines Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Cat Medicines Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Cat Medicines Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Cat Medicines Sales Volume Share by Type (2021-2026) Table 25. Global Cat Medicines Sales Volume Share by Type (2027-2032) Table 26. Global Cat Medicines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cat Medicines Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Cat Medicines Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Cat Medicines Sales Value Share by Type (2021-2026) Table 30. Global Cat Medicines Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Online Table 32. Significant Companies of Offline Table 33. Global Cat Medicines Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Cat Medicines Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Cat Medicines Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Cat Medicines Sales Volume Share by Application (2021-2026) Table 37. Global Cat Medicines Sales Volume Share by Application (2027-2032) Table 38. Global Cat Medicines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cat Medicines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Cat Medicines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Cat Medicines Sales Value Share by Application (2021-2026) Table 42. Global Cat Medicines Sales Value Share by Application (2027-2032) Table 43. Global Cat Medicines Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Cat Medicines Sales by Region (2021-2026) & (Tons) Table 45. Global Cat Medicines Sales Market Share by Region (2021-2026) Table 46. Global Cat Medicines Sales by Region (2027-2032) & (Tons) Table 47. Global Cat Medicines Sales Market Share by Region (2027-2032) Table 48. Global Cat Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Cat Medicines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Cat Medicines Sales Value Share by Region (2021-2026) Table 51. Global Cat Medicines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Cat Medicines Sales Value Share by Region (2027-2032) Table 53. Global Cat Medicines Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Cat Medicines Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Cat Medicines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Cat Medicines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Cat Medicines Sales by Country (2021-2026) & (Tons) Table 58. Global Cat Medicines Sales Market Share by Country (2021-2026) Table 59. Global Cat Medicines Sales by Country (2027-2032) & (Tons) Table 60. Global Cat Medicines Sales Market Share by Country (2027-2032) Table 61. Global Cat Medicines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Cat Medicines Sales Value Market Share by Country (2021-2026) Table 63. Global Cat Medicines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Cat Medicines Sales Value Market Share by Country (2027-2032) Table 65. Wuhan Chopperlvya Animal Health Company Information Table 66. Wuhan Chopperlvya Animal Health Business Overview Table 67. Wuhan Chopperlvya Animal Health Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Wuhan Chopperlvya Animal Health Cat Medicines Product Portfolio Table 69. Wuhan Chopperlvya Animal Health Recent Development Table 70. Zoetis Company Information Table 71. Zoetis Business Overview Table 72. Zoetis Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Zoetis Cat Medicines Product Portfolio Table 74. Zoetis Recent Development Table 75. Tianjin Ringpu Bio-technology Company Information Table 76. Tianjin Ringpu Bio-technology Business Overview Table 77. Tianjin Ringpu Bio-technology Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Tianjin Ringpu Bio-technology Cat Medicines Product Portfolio Table 79. Tianjin Ringpu Bio-technology Recent Development Table 80. Nanjing Jindun Animal Pharmaceutical Company Information Table 81. Nanjing Jindun Animal Pharmaceutical Business Overview Table 82. Nanjing Jindun Animal Pharmaceutical Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Nanjing Jindun Animal Pharmaceutical Cat Medicines Product Portfolio Table 84. Nanjing Jindun Animal Pharmaceutical Recent Development Table 85. Jining Wanhe Biotechnology (Belcol) Company Information Table 86. Jining Wanhe Biotechnology (Belcol) Business Overview Table 87. Jining Wanhe Biotechnology (Belcol) Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Jining Wanhe Biotechnology (Belcol) Cat Medicines Product Portfolio Table 89. Jining Wanhe Biotechnology (Belcol) Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Pfizer Cat Medicines Product Portfolio Table 94. Pfizer Recent Development Table 95. Harbin Pharmaceutical Group Company Information Table 96. Harbin Pharmaceutical Group Business Overview Table 97. Harbin Pharmaceutical Group Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Harbin Pharmaceutical Group Cat Medicines Product Portfolio Table 99. Harbin Pharmaceutical Group Recent Development Table 100. Taizhou Boleideli Biotechnology Company Information Table 101. Taizhou Boleideli Biotechnology Business Overview Table 102. Taizhou Boleideli Biotechnology Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Taizhou Boleideli Biotechnology Cat Medicines Product Portfolio Table 104. Taizhou Boleideli Biotechnology Recent Development Table 105. Virbac Company Information Table 106. Virbac Business Overview Table 107. Virbac Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Virbac Cat Medicines Product Portfolio Table 109. Virbac Recent Development Table 110. Vetoquinol Company Information Table 111. Vetoquinol Business Overview Table 112. Vetoquinol Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Vetoquinol Cat Medicines Product Portfolio Table 114. Vetoquinol Recent Development Table 115. Merck Company Information Table 116. Merck Business Overview Table 117. Merck Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Merck Cat Medicines Product Portfolio Table 119. Merck Recent Development Table 120. IDEXX Company Information Table 121. IDEXX Business Overview Table 122. IDEXX Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. IDEXX Cat Medicines Product Portfolio Table 124. IDEXX Recent Development Table 125. Elanco Company Information Table 126. Elanco Business Overview Table 127. Elanco Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Elanco Cat Medicines Product Portfolio Table 129. Elanco Recent Development Table 130. Dechra Veterinary Products Company Information Table 131. Dechra Veterinary Products Business Overview Table 132. Dechra Veterinary Products Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Dechra Veterinary Products Cat Medicines Product Portfolio Table 134. Dechra Veterinary Products Recent Development Table 135. Ceva Company Information Table 136. Ceva Business Overview Table 137. Ceva Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Ceva Cat Medicines Product Portfolio Table 139. Ceva Recent Development Table 140. Boehringer Ingelheim Company Information Table 141. Boehringer Ingelheim Business Overview Table 142. Boehringer Ingelheim Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. Boehringer Ingelheim Cat Medicines Product Portfolio Table 144. Boehringer Ingelheim Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Cat Medicines Distributors List Table 148. Cat Medicines Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Cat Medicines Product Image Figure 2. Global Cat Medicines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cat Medicines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cat Medicines Sales (2021-2032) & (Tons) Figure 5. Global Cat Medicines Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Cat Medicines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antiparasitic Drugs Image Figure 10. Dermatological Drugs Image Figure 11. Digestive System Drugs Image Figure 12. Others Image Figure 13. Global Cat Medicines Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Cat Medicines Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Cat Medicines Sales Volume Share by Type (2021-2032) Figure 16. Global Cat Medicines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cat Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cat Medicines Sales Value Share by Type (2021-2032) Figure 19. Online Image Figure 20. Offline Image Figure 21. Global Cat Medicines Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Cat Medicines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Cat Medicines Sales Volume Share by Application (2021-2032) Figure 24. Global Cat Medicines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Cat Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Cat Medicines Sales Value Share by Application (2021-2032) Figure 27. Global Cat Medicines Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Cat Medicines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Cat Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Cat Medicines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Cat Medicines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Cat Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Cat Medicines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Cat Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Cat Medicines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cat Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Cat Medicines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Cat Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Cat Medicines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Cat Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Cat Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Cat Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Cat Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Cat Medicines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Cat Medicines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Antiparasitic Drugs
  • Dermatological Drugs
  • Digestive System Drugs
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Wuhan Chopperlvya Animal Health
  • Zoetis
  • Tianjin Ringpu Bio-technology
  • Nanjing Jindun Animal Pharmaceutical
  • Jining Wanhe Biotechnology (Belcol)
  • Pfizer
  • Harbin Pharmaceutical Group
  • Taizhou Boleideli Biotechnology
  • Virbac
  • Vetoquinol
  • Merck
  • IDEXX
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cat Medicines Sales Value (2021-2032)
  4. 1.2.2 Global Cat Medicines Sales Volume (2021-2032)
  5. 1.2.3 Global Cat Medicines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cat Medicines Market Dynamics
  1. 2.1 Cat Medicines Industry Trends
  2. 2.2 Cat Medicines Industry Drivers
  3. 2.3 Cat Medicines Industry Opportunities and Challenges
  4. 2.4 Cat Medicines Industry Restraints
3 Cat Medicines Market by Company
  1. 3.1 Global Cat Medicines Company Revenue Ranking in 2025
  2. 3.2 Global Cat Medicines Revenue by Company (2021-2026)
  3. 3.3 Global Cat Medicines Sales Volume by Company (2021-2026)
  4. 3.4 Global Cat Medicines Average Price by Company (2021-2026)
  5. 3.5 Global Cat Medicines Company Ranking (2024-2026)
  6. 3.6 Global Cat Medicines Company Manufacturing Base and Headquarters
  7. 3.7 Global Cat Medicines Company Product Type and Application
  8. 3.8 Global Cat Medicines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cat Medicines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cat Medicines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cat Medicines Market by Type
  1. 4.1 Cat Medicines Type Introduction
  2. 4.1.1 Antiparasitic Drugs
  3. 4.1.2 Dermatological Drugs
  4. 4.1.3 Digestive System Drugs
  5. 4.1.4 Others
  6. 4.2 Global Cat Medicines Sales Volume by Type
  7. 4.2.1 Global Cat Medicines Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cat Medicines Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Cat Medicines Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Cat Medicines Sales Value by Type
  11. 4.3.1 Global Cat Medicines Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cat Medicines Sales Value by Type (2021-2032)
  13. 4.3.3 Global Cat Medicines Sales Value Share by Type (2021-2032)
5 Cat Medicines Market by Application
  1. 5.1 Cat Medicines Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global Cat Medicines Sales Volume by Application
  5. 5.2.1 Global Cat Medicines Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cat Medicines Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Cat Medicines Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Cat Medicines Sales Value by Application
  9. 5.3.1 Global Cat Medicines Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Cat Medicines Sales Value by Application (2021-2032)
  11. 5.3.3 Global Cat Medicines Sales Value Share by Application (2021-2032)
6 Cat Medicines Regional Sales and Value Analysis
  1. 6.1 Global Cat Medicines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cat Medicines Sales by Region (2021-2032)
  3. 6.2.1 Global Cat Medicines Sales by Region: 2021-2026
  4. 6.2.2 Global Cat Medicines Sales by Region (2027-2032)
  5. 6.3 Global Cat Medicines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cat Medicines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cat Medicines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cat Medicines Sales Value by Region (2027-2032)
  9. 6.5 Global Cat Medicines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cat Medicines Sales Value (2021-2032)
  12. 6.6.2 North America Cat Medicines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cat Medicines Sales Value (2021-2032)
  15. 6.7.2 Europe Cat Medicines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cat Medicines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cat Medicines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cat Medicines Sales Value (2021-2032)
  21. 6.9.2 South America Cat Medicines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cat Medicines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cat Medicines Sales Value Share by Country, 2025 VS 2032
7 Cat Medicines Country-level Sales and Value Analysis
  1. 7.1 Global Cat Medicines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cat Medicines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cat Medicines Sales by Country (2021-2032)
  4. 7.3.1 Global Cat Medicines Sales by Country (2021-2026)
  5. 7.3.2 Global Cat Medicines Sales by Country (2027-2032)
  6. 7.4 Global Cat Medicines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cat Medicines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cat Medicines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cat Medicines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cat Medicines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cat Medicines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cat Medicines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cat Medicines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cat Medicines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cat Medicines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cat Medicines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cat Medicines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cat Medicines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cat Medicines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cat Medicines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cat Medicines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cat Medicines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cat Medicines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cat Medicines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cat Medicines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cat Medicines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cat Medicines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cat Medicines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cat Medicines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cat Medicines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cat Medicines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cat Medicines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cat Medicines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cat Medicines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cat Medicines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cat Medicines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cat Medicines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cat Medicines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cat Medicines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cat Medicines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cat Medicines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cat Medicines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cat Medicines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cat Medicines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cat Medicines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cat Medicines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cat Medicines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cat Medicines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cat Medicines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cat Medicines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cat Medicines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cat Medicines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cat Medicines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cat Medicines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cat Medicines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cat Medicines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cat Medicines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cat Medicines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cat Medicines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cat Medicines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cat Medicines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cat Medicines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cat Medicines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cat Medicines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cat Medicines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cat Medicines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cat Medicines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cat Medicines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cat Medicines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cat Medicines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cat Medicines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cat Medicines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cat Medicines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cat Medicines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cat Medicines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cat Medicines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cat Medicines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cat Medicines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cat Medicines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cat Medicines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cat Medicines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cat Medicines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cat Medicines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cat Medicines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cat Medicines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cat Medicines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cat Medicines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cat Medicines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cat Medicines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cat Medicines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cat Medicines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cat Medicines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Chopperlvya Animal Health
  2. 8.1.1 Wuhan Chopperlvya Animal Health Company Information
  3. 8.1.2 Wuhan Chopperlvya Animal Health Business Overview
  4. 8.1.3 Wuhan Chopperlvya Animal Health Cat Medicines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Chopperlvya Animal Health Cat Medicines Product Portfolio
  6. 8.1.5 Wuhan Chopperlvya Animal Health Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Cat Medicines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Cat Medicines Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Tianjin Ringpu Bio-technology
  14. 8.3.1 Tianjin Ringpu Bio-technology Company Information
  15. 8.3.2 Tianjin Ringpu Bio-technology Business Overview
  16. 8.3.3 Tianjin Ringpu Bio-technology Cat Medicines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tianjin Ringpu Bio-technology Cat Medicines Product Portfolio
  18. 8.3.5 Tianjin Ringpu Bio-technology Recent Developments
  19. 8.4 Nanjing Jindun Animal Pharmaceutical
  20. 8.4.1 Nanjing Jindun Animal Pharmaceutical Company Information
  21. 8.4.2 Nanjing Jindun Animal Pharmaceutical Business Overview
  22. 8.4.3 Nanjing Jindun Animal Pharmaceutical Cat Medicines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Jindun Animal Pharmaceutical Cat Medicines Product Portfolio
  24. 8.4.5 Nanjing Jindun Animal Pharmaceutical Recent Developments
  25. 8.5 Jining Wanhe Biotechnology (Belcol)
  26. 8.5.1 Jining Wanhe Biotechnology (Belcol) Company Information
  27. 8.5.2 Jining Wanhe Biotechnology (Belcol) Business Overview
  28. 8.5.3 Jining Wanhe Biotechnology (Belcol) Cat Medicines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jining Wanhe Biotechnology (Belcol) Cat Medicines Product Portfolio
  30. 8.5.5 Jining Wanhe Biotechnology (Belcol) Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Cat Medicines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Cat Medicines Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Harbin Pharmaceutical Group
  38. 8.7.1 Harbin Pharmaceutical Group Company Information
  39. 8.7.2 Harbin Pharmaceutical Group Business Overview
  40. 8.7.3 Harbin Pharmaceutical Group Cat Medicines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Pharmaceutical Group Cat Medicines Product Portfolio
  42. 8.7.5 Harbin Pharmaceutical Group Recent Developments
  43. 8.8 Taizhou Boleideli Biotechnology
  44. 8.8.1 Taizhou Boleideli Biotechnology Company Information
  45. 8.8.2 Taizhou Boleideli Biotechnology Business Overview
  46. 8.8.3 Taizhou Boleideli Biotechnology Cat Medicines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Taizhou Boleideli Biotechnology Cat Medicines Product Portfolio
  48. 8.8.5 Taizhou Boleideli Biotechnology Recent Developments
  49. 8.9 Virbac
  50. 8.9.1 Virbac Company Information
  51. 8.9.2 Virbac Business Overview
  52. 8.9.3 Virbac Cat Medicines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Virbac Cat Medicines Product Portfolio
  54. 8.9.5 Virbac Recent Developments
  55. 8.10 Vetoquinol
  56. 8.10.1 Vetoquinol Company Information
  57. 8.10.2 Vetoquinol Business Overview
  58. 8.10.3 Vetoquinol Cat Medicines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Vetoquinol Cat Medicines Product Portfolio
  60. 8.10.5 Vetoquinol Recent Developments
  61. 8.11 Merck
  62. 8.11.1 Merck Company Information
  63. 8.11.2 Merck Business Overview
  64. 8.11.3 Merck Cat Medicines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Merck Cat Medicines Product Portfolio
  66. 8.11.5 Merck Recent Developments
  67. 8.12 IDEXX
  68. 8.12.1 IDEXX Company Information
  69. 8.12.2 IDEXX Business Overview
  70. 8.12.3 IDEXX Cat Medicines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 IDEXX Cat Medicines Product Portfolio
  72. 8.12.5 IDEXX Recent Developments
  73. 8.13 Elanco
  74. 8.13.1 Elanco Company Information
  75. 8.13.2 Elanco Business Overview
  76. 8.13.3 Elanco Cat Medicines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Elanco Cat Medicines Product Portfolio
  78. 8.13.5 Elanco Recent Developments
  79. 8.14 Dechra Veterinary Products
  80. 8.14.1 Dechra Veterinary Products Company Information
  81. 8.14.2 Dechra Veterinary Products Business Overview
  82. 8.14.3 Dechra Veterinary Products Cat Medicines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Dechra Veterinary Products Cat Medicines Product Portfolio
  84. 8.14.5 Dechra Veterinary Products Recent Developments
  85. 8.15 Ceva
  86. 8.15.1 Ceva Company Information
  87. 8.15.2 Ceva Business Overview
  88. 8.15.3 Ceva Cat Medicines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ceva Cat Medicines Product Portfolio
  90. 8.15.5 Ceva Recent Developments
  91. 8.16 Boehringer Ingelheim
  92. 8.16.1 Boehringer Ingelheim Company Information
  93. 8.16.2 Boehringer Ingelheim Business Overview
  94. 8.16.3 Boehringer Ingelheim Cat Medicines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Boehringer Ingelheim Cat Medicines Product Portfolio
  96. 8.16.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cat Medicines Value Chain Analysis
  2. 9.1.1 Cat Medicines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cat Medicines Sales Mode & Process
  6. 9.2 Cat Medicines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cat Medicines Distributors
  9. 9.2.3 Cat Medicines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst